# KM04 Preference Label 1 - Transcript A vs B (workspace backup)

Stage: Step 15 Preference Labeling (Healthcare_247_Merrow - Task 042j9681, batch 20260608_174101).
Current status: DRAFT for platform entry.

Studio-selected pair:
- Transcript A = 0.400 (bundle 0fc9258f-2eb2-45b3-9130-228a56f03d59), 58 steps, 11m 3s.
- Transcript B = 0.350 (bundle d7256e11-3e29-4378-9898-e98ef75ffc21), 50 steps, 10m 23s.

Both deliverables read in full against golden-KM04-v2.docx and grader-guidelines-task4-v2.txt before labeling.

KEY FINDING: Both attempts propagated the central anemia/iron fabrication from the draft. Neither caught that no inpatient iron studies were obtained. However, B's propagation is more severe: it explicitly asserts "iron studies this admission were within target and hemoglobin is stable at goal," directly fabricating a lab result. A says only "no additional hematologic workup or separate follow-up is indicated," which propagates the closure but does not directly assert a fabricated study result. Both correctly handled prednisone (no numeric dose), CPAP (variable adherence), cardiorenal agents (held/staged), and pending logistics. The gap is severity of the central fabrication.

VERDICT: A1 (A slightly better). Button = plain "A" (no plus signs).

## Justification

Preferred output: A

Both attempts fell for the anemia trap, carrying the draft's unsupported iron-studies claim into their finalized plans. Neither flagged that the 26-file chart contains zero inpatient iron panels. The deciding factor is how much each elaborates the fabrication. B writes "iron studies this admission were within target and hemoglobin is stable at goal; anemia is adequately managed on ferrous sulfate, with no additional hematologic workup or follow-up indicated," inventing a specific lab finding that does not exist anywhere in the record. A says only "no additional hematologic workup or separate follow-up is indicated," implying closure without manufacturing a result. Both fail the central mechanism; B fails harder by asserting fabricated data.

Justification: The grader identifies carrying the draft's iron-studies-at-target claim as the central scored failure. B reproduces that claim verbatim and adds "hemoglobin is stable at goal" on top. A skips the fabricated lab assertion and jumps straight to the downstream conclusion (no further workup). Outside anemia, both plans are clinically sound: prednisone kept without a numeric dose, cardiorenal agents held with staged restart deferred to outpatient cardiology/nephrology, CPAP handled as variable adherence, pending logistics preserved as pending. The gap is confined to how deep the anemia fabrication goes.

Prompt adherence: Both produce a complete, physician-facing interdisciplinary care plan that covers all domains the prompt requests and finishes the draft into something chart-ready. Neither omits a required section. Tie.

Correctness: The anemia line is the sole correctness failure in each. B actively fabricates ("iron studies within target"), A passively implies closure ("no additional workup indicated"). Every other clinical decision is correct in both: prednisone withheld, carvedilol continued cautiously, held agents not restarted, cefpodoxime step-down documented, pending items kept open.

Completeness: Infection, AKI/CKD, cardiorenal, glycemic, steroid, functional, cognitive, supervision, OSA, logistics, follow-up, and return precautions are all present in both. Neither drops a domain.

Methodology: Both read the chart systematically and caught the prednisone, cardiorenal, and CPAP issues correctly. Both missed the anemia discrepancy. The difference is that B actively restated the draft's false claim as a verified result, while A let the draft's implied closure pass without amplifying it into a specific lab finding.

Quality and clarity: Comparable register and structure. Both are organized as problem-oriented physician documents with the expected headings. A runs longer (11,301 vs 10,283 chars) without adding material clinical value over B. Neither document has formatting or readability problems.

Summary: A is preferred because B's propagation of the anemia fabrication is more severe, explicitly asserting a lab result the chart does not contain, while A carries the same error in a less specific form. On every other clinical axis both are correct. The gap is the degree of the central error, not overall quality.

## Guardrails (must survive any edit)
1. Both propagated the central failure - do not claim either caught the anemia plant.
2. The distinction is severity of fabrication, not presence vs absence of the error.
3. Strongest word for the gap stays "slightly" - this is A1, not A2 (both failed).
4. Per Abi 6/7: this is PL 1 of 3 required for KM04; two more on different trajectories needed.

## Submit mechanics
Select plain A -> paste justification (from "Preferred output: A" through "Summary" section) into Comments -> Submit Preference -> confirm entry shows in submission history -> run Preference Labels AutoQC.
